Literature DB >> 29601139

Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.

Rui Wu1, Dong-Aolei An1, Ruo-Yang Shi1, Bing-Hua Chen1, Meng Jiang2, Andrew Bacyinski3, Tong-Tong Han4, Jiani Hu5, Jian-Rong Xu1, Lian-Ming Wu1.   

Abstract

BACKGROUND: Previous studies have shown that diffusion-weighted imaging (DWI) is sensitive to myocardial fibrosis in ischemic and nonischemic cardiomyopathy.
PURPOSE: To explore the prognostic value of apparent diffusion coefficient (ADC) for detecting myocardial fibrosis and its relationship to the contractile function in hypertrophic cardiomyopathy (HCM). STUDY TYPE: Prospective. POPULATION: A total of 45 HCM patients and 20 controls. FIELD STRENGTH/SEQUENCE: 3.0T cardiac MRI. The cardiac MR sequences included cine, T1 mapping, and DWI. ASSESSMENT: According to the presence of late gadolinium enhancement (LGE) and the extracellular volume (ECV) values (+2 SD of control subjects), respectively, reader W and reader J assessed the value of ADC of each segment for detecting myocardial fibrosis and its relationship to impaired contractile function in HCM patients. STATISTICAL TESTS: Independent sample t-test, Pearson analysis, and intraclass correlation (ICC).
RESULTS: The value of ECV was 23.6 ± 3.0% for control. ECV ≥ 29.6% and ECV < 29.6% groups were classified. ADC values in the ECV ≥ 29.6% group were significantly increased compared to the ECV < 29.6% group, (2.41 ± 0.23 μm2 /ms vs. 2.03 ± 0.16 μm2 /ms, P < 0.005). Compared to the LGE - group, ECV (32.1 ± 2.3% vs. 29.0 ± 2.8%, P < 0.005) and ADC (2.60 ± 0.18 μm2 /ms vs. 2.10 ± 0.07 μm2 /ms, P < 0.005) values were significantly increased in the LGE + group. ADC values were linearly associated with ECV values (R2  = 0.65) in HCM patients. ADC values were linearly associated with circumferential and longitudinal strain (R2  = 0.60, R2  = 0.46), as well as circumferential, longitudinal, and radial strain rate (R2  = 0.13, R2  = 0.25, R2  = 0.17, respectively). DATA
CONCLUSION: Contractile dysfunction in HCM is predominantly associated with ADC, which is a feasible alternative to ECV and LGE for detecting myocardial fibrosis. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;48:1139-1146.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  DWI; ECV; HCM; LGE; apparent diffusion coefficient; tissue tracking

Mesh:

Substances:

Year:  2018        PMID: 29601139     DOI: 10.1002/jmri.26016

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

1.  Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy.

Authors:  Pierpaolo Palumbo; Francesco Masedu; Camilla De Cataldo; Ester Cannizzaro; Federico Bruno; Silvia Pradella; Francesco Arrigoni; Marco Valenti; Alessandra Splendiani; Antonio Barile; Andrea Giovagnoni; Carlo Masciocchi; Ernesto Di Cesare
Journal:  Radiol Med       Date:  2021-12-11       Impact factor: 3.469

2.  Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.

Authors:  Frank J Raucci; Meng Xu; Kristen George-Durrett; Kimberly Crum; James C Slaughter; David A Parra; Larry W Markham; Jonathan H Soslow
Journal:  J Cardiovasc Magn Reson       Date:  2021-04-29       Impact factor: 5.364

3.  Efficacy of Novel Noncontrast Cardiac Magnetic Resonance Methods in Indicating Fibrosis in Hypertrophic Cardiomyopathy.

Authors:  Maedeh Sharifian; Nahid Rezaeian; Sanaz Asadian; Ali Mohammadzadeh; Ali Nahardani; Kianosh Kasani; Yaser Toloueitabar; Ali Mohammad Farahmand; Leila Hosseini
Journal:  Cardiol Res Pract       Date:  2021-05-24       Impact factor: 1.866

4.  Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes.

Authors:  Arka Das; Christopher Kelly; Irvin Teh; Christopher Nguyen; Louise A E Brown; Amrit Chowdhary; Nicholas Jex; Sharmaine Thirunavukarasu; Noor Sharrack; Miroslawa Gorecka; Peter P Swoboda; John P Greenwood; Peter Kellman; James C Moon; Rhodri H Davies; Luis R Lopes; George Joy; Sven Plein; Jürgen E Schneider; Erica Dall'Armellina
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-02-22       Impact factor: 6.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.